MedDataX Logo

A Multi-center Study on Human Microecology Assisted Diagnosis of Colorectal Cancer

NCT ID: NCT05998915

Last Updated: 2023-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

5 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As for this research，we want to find whether the intestinal microecology (flora, peptidoglycan fragments) have certain distribution characteristics in colorectal diseases; whether it can predict the development of disease/as a prognostic indicator.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We even want to find whether it can predict the development of disease/as a prognostic indicator.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Microecology；Colorectal Disease；Auxiliary Diagnosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Colorectal Cancer(CRC)

People who is diagnosed with CRC by colonoscopy and pathological biopsy

observe only

Intervention Type OTHER

observe only

Inflammatory Bowel Disease

People who is diagnosed with IBD by colonoscopy and pathological biopsy

observe only

Intervention Type OTHER

observe only

Colorectal adenoma(CRA)/adenomatous polyposis

People who is diagnosed with CRA by colonoscopy and pathological biopsy

observe only

Intervention Type OTHER

observe only

Non-adenomatous polyps

People who is diagnosed with non-adenomatous polyps by colonoscopy and pathological biopsy

observe only

Intervention Type OTHER

observe only

Irritable bowel syndrome

People who is diagnosed with IBS by colonoscopy and pathological biopsy

observe only

Intervention Type OTHER

observe only

normal

People who has no obvious abnormality in the whole colon

observe only

Intervention Type OTHER

observe only

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

observe only

observe only

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* people who is going to get the colonoscopy examination

Exclusion Criteria

* people who was diagnosed as one cancer，expect for CRC; who has had the antibiotics or the medicine that treats for colorectal disease, except for medical probiotics, in one month; who has had the laxative and the colonscopy in one week; who had a operation in three month.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zhujiang Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhujiang Hospital of Southern Medical University

Guangzhou, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

钟 典

Role: CONTACT

Phone: 18928794133

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hongwei Zhou, Professor

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CALM2102

Identifier Type: -

Identifier Source: org_study_id